Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 37 (RPL32P37) is a human processed pseudogene found on chromosome 19[4]. It is derived from the ribosomal protein L32 gene, whose protein product is a component of the large 60S ribosomal subunit and is involved in protein synthesis[3][5]. Unlike its parental gene, RPL32P37 does not encode a functional protein, and there is no evidence it participates in biological processes, disease mechanisms, or drug interactions. No aliases, biological functions, or disease associations are reported for RPL32P37. Processed pseudogenes like RPL32P37 arise through retrotransposon-mediated duplication, typically do not produce proteins, and have minimal, if any, functional significance in cellular regulation or therapeutic intervention[2][4]. Other RPL32 pseudogenes (e.g., RPL32P3[1]) have been implicated in regulatory roles—such as modulating protein expression or influencing tumor microenvironments—but these findings do not apply to RPL32P37 based on the available data, and no publications indicate that RPL32P37 has been studied in this context[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 37 (RPL32P37).